Revvity, Inc. (RVTY)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Revvity, Inc. (RVTY)
Go deeper and ask any question about RVTY
Company Performance
Current Price
as of Oct 02, 2024$125.08
P/E Ratio
70.13
Market Cap
$15.35B
Description
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Metrics
Overview
- HQWaltham, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerRVTY
- Price$125.08+0.51%
Trading Information
- Market Cap$15.35B
- Float99.60%
- Average Daily Volume (1m)684,545
- Average Daily Volume (3m)752,321
- EPS$1.78
Company
- Revenue$2.71B
- Rev Growth (1yr)-2.45%
- Net Income$72.61M
- Gross Margin55.73%
- EBITDA Margin30.18%
- EBITDA$208.77M
- EV$14.99B
- EV/Revenue5.54
- P/E70.13
- P/S5.67
Documents
Factset Street Account
Earnings Calls
Wikipedia